Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Sep 15;100(6):1538–1546. doi: 10.1172/JCI119677

Production and physiological actions of anandamide in the vasculature of the rat kidney.

D G Deutsch 1, M S Goligorsky 1, P C Schmid 1, R J Krebsbach 1, H H Schmid 1, S K Das 1, S K Dey 1, G Arreaza 1, C Thorup 1, G Stefano 1, L C Moore 1
PMCID: PMC508335  PMID: 9294122

Abstract

The endogenous cannabinoid receptor agonist anandamide is present in central and peripheral tissues. As the kidney contains both the amidase that degrades anandamide and transcripts for anandamide receptors, we characterized the molecular components of the anandamide signaling system and the vascular effects of exogenous anandamide in the kidney. We show that anandamide is present in kidney homogenates, cultured renal endothelial cells (EC), and mesangial cells; these cells also contain anandamide amidase. Reverse-transcriptase PCR shows that EC contain transcripts for cannabinoid type 1 (CB1) receptors, while mesangial cells have mRNA for both CB1 and CB2 receptors. EC exhibit specific, high-affinity binding of anandamide (Kd = 27.4 nM). Anandamide (1 microM) vasodilates juxtamedullary afferent arterioles perfused in vitro; the vasodilation can be blocked by nitric oxide (NO) synthase inhibition with L-NAME (0.1 mM) or CB1 receptor antagonism with SR 141716A (1 microM), but not by indomethacin (10 microM). Anandamide (10 nM) stimulates CB1-receptor-mediated NO release from perfused renal arterial segments; a similar effect was seen in EC. Finally, anandamide (1 microM) produces a NO-mediated inhibition of KCl-stimulated [3H]norepinephrine release from sympathetic nerves on isolated renal arterial segments. Hence, an anandamide signaling system is present in the kidney, where it exerts significant vasorelaxant and neuromodulatory effects.

Full Text

The Full Text of this article is available as a PDF (239.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Casellas D., Moore L. C. Autoregulation and tubuloglomerular feedback in juxtamedullary glomerular arterioles. Am J Physiol. 1990 Mar;258(3 Pt 2):F660–F669. doi: 10.1152/ajprenal.1990.258.3.F660. [DOI] [PubMed] [Google Scholar]
  2. Casellas D., Navar L. G. In vitro perfusion of juxtamedullary nephrons in rats. Am J Physiol. 1984 Mar;246(3 Pt 2):F349–F358. doi: 10.1152/ajprenal.1984.246.3.F349. [DOI] [PubMed] [Google Scholar]
  3. Chang M. C., Berkery D., Schuel R., Laychock S. G., Zimmerman A. M., Zimmerman S., Schuel H. Evidence for a cannabinoid receptor in sea urchin sperm and its role in blockade of the acrosome reaction. Mol Reprod Dev. 1993 Dec;36(4):507–516. doi: 10.1002/mrd.1080360416. [DOI] [PubMed] [Google Scholar]
  4. Das S. K., Paria B. C., Chakraborty I., Dey S. K. Cannabinoid ligand-receptor signaling in the mouse uterus. Proc Natl Acad Sci U S A. 1995 May 9;92(10):4332–4336. doi: 10.1073/pnas.92.10.4332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Desarnaud F., Cadas H., Piomelli D. Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization. J Biol Chem. 1995 Mar 17;270(11):6030–6035. doi: 10.1074/jbc.270.11.6030. [DOI] [PubMed] [Google Scholar]
  6. Deutsch D. G., Chin S. A. Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem Pharmacol. 1993 Sep 1;46(5):791–796. doi: 10.1016/0006-2952(93)90486-g. [DOI] [PubMed] [Google Scholar]
  7. Devane W. A., Axelrod J. Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes. Proc Natl Acad Sci U S A. 1994 Jul 5;91(14):6698–6701. doi: 10.1073/pnas.91.14.6698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Devane W. A., Hanus L., Breuer A., Pertwee R. G., Stevenson L. A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 1992 Dec 18;258(5090):1946–1949. doi: 10.1126/science.1470919. [DOI] [PubMed] [Google Scholar]
  9. Egi Y., Matsumura Y., Murata S., Umekawa T., Hisaki K., Takaoka M., Morimoto S. The effects of NG-nitro-L-arginine, a nitric oxide synthase inhibitor, on norepinephrine overflow and antidiuresis induced by stimulation of renal nerves in anesthetized dogs. J Pharmacol Exp Ther. 1994 May;269(2):529–535. [PubMed] [Google Scholar]
  10. Ellis E. F., Moore S. F., Willoughby K. A. Anandamide and delta 9-THC dilation of cerebral arterioles is blocked by indomethacin. Am J Physiol. 1995 Dec;269(6 Pt 2):H1859–H1864. doi: 10.1152/ajpheart.1995.269.6.H1859. [DOI] [PubMed] [Google Scholar]
  11. FOLCH J., LEES M., SLOANE STANLEY G. H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957 May;226(1):497–509. [PubMed] [Google Scholar]
  12. Felder C. C., Nielsen A., Briley E. M., Palkovits M., Priller J., Axelrod J., Nguyen D. N., Richardson J. M., Riggin R. M., Koppel G. A. Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. FEBS Lett. 1996 Sep 16;393(2-3):231–235. doi: 10.1016/0014-5793(96)00891-5. [DOI] [PubMed] [Google Scholar]
  13. Galiègue S., Mary S., Marchand J., Dussossoy D., Carrière D., Carayon P., Bouaboula M., Shire D., Le Fur G., Casellas P. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem. 1995 Aug 15;232(1):54–61. doi: 10.1111/j.1432-1033.1995.tb20780.x. [DOI] [PubMed] [Google Scholar]
  14. Howlett A. C., Bidaut-Russell M., Devane W. A., Melvin L. S., Johnson M. R., Herkenham M. The cannabinoid receptor: biochemical, anatomical and behavioral characterization. Trends Neurosci. 1990 Oct;13(10):420–423. doi: 10.1016/0166-2236(90)90124-s. [DOI] [PubMed] [Google Scholar]
  15. Iijima K., Moore L. C., Goligorsky M. S. Syncytial organization of cultured rat mesangial cells. Am J Physiol. 1991 Jun;260(6 Pt 2):F848–F855. doi: 10.1152/ajprenal.1991.260.6.F848. [DOI] [PubMed] [Google Scholar]
  16. Kempe K., Hsu F. F., Bohrer A., Turk J. Isotope dilution mass spectrometric measurements indicate that arachidonylethanolamide, the proposed endogenous ligand of the cannabinoid receptor, accumulates in rat brain tissue post mortem but is contained at low levels in or is absent from fresh tissue. J Biol Chem. 1996 Jul 19;271(29):17287–17295. doi: 10.1074/jbc.271.29.17287. [DOI] [PubMed] [Google Scholar]
  17. Kruszka K. K., Gross R. W. The ATP- and CoA-independent synthesis of arachidonoylethanolamide. A novel mechanism underlying the synthesis of the endogenous ligand of the cannabinoid receptor. J Biol Chem. 1994 May 20;269(20):14345–14348. [PubMed] [Google Scholar]
  18. Lake K. D., Martin B. R., Kunos G., Varga K. Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats. Hypertension. 1997 May;29(5):1204–1210. doi: 10.1161/01.hyp.29.5.1204. [DOI] [PubMed] [Google Scholar]
  19. Mackie K., Hille B. Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc Natl Acad Sci U S A. 1992 May 1;89(9):3825–3829. doi: 10.1073/pnas.89.9.3825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Matsuda L. A., Lolait S. J., Brownstein M. J., Young A. C., Bonner T. I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 1990 Aug 9;346(6284):561–564. doi: 10.1038/346561a0. [DOI] [PubMed] [Google Scholar]
  21. Matsuoka H., Nishida H., Nomura G., Van Vliet B. N., Toshima H. Hypertension induced by nitric oxide synthesis inhibition is renal nerve dependent. Hypertension. 1994 Jun;23(6 Pt 2):971–975. doi: 10.1161/01.hyp.23.6.971. [DOI] [PubMed] [Google Scholar]
  22. Mechoulam R., Hanus L., Martin B. R. Search for endogenous ligands of the cannabinoid receptor. Biochem Pharmacol. 1994 Oct 18;48(8):1537–1544. doi: 10.1016/0006-2952(94)90197-x. [DOI] [PubMed] [Google Scholar]
  23. Munro S., Thomas K. L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 1993 Sep 2;365(6441):61–65. doi: 10.1038/365061a0. [DOI] [PubMed] [Google Scholar]
  24. Nah S. Y., Saya D., Vogel Z. Cannabinoids inhibit agonist-stimulated formation of inositol phosphates in rat hippocampal cultures. Eur J Pharmacol. 1993 Jun 15;246(1):19–24. doi: 10.1016/0922-4106(93)90004-s. [DOI] [PubMed] [Google Scholar]
  25. Omeir R. L., Chin S., Hong Y., Ahern D. G., Deutsch D. G. Arachidonoyl ethanolamide-[1,2-14C] as a substrate for anandamide amidase. Life Sci. 1995;56(23-24):1999–2005. doi: 10.1016/0024-3205(95)00181-5. [DOI] [PubMed] [Google Scholar]
  26. Paria B. C., Das S. K., Andrews G. K., Dey S. K. Expression of the epidermal growth factor receptor gene is regulated in mouse blastocysts during delayed implantation. Proc Natl Acad Sci U S A. 1993 Jan 1;90(1):55–59. doi: 10.1073/pnas.90.1.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Paria B. C., Deutsch D. D., Dey S. K. The uterus is a potential site for anandamide synthesis and hydrolysis: differential profiles of anandamide synthase and hydrolase activities in the mouse uterus during the periimplantation period. Mol Reprod Dev. 1996 Oct;45(2):183–192. doi: 10.1002/(SICI)1098-2795(199610)45:2<183::AID-MRD11>3.0.CO;2-2. [DOI] [PubMed] [Google Scholar]
  28. Pertwee R. G., Fernando S. R., Griffin G., Abadji V., Makriyannis A. Effect of phenylmethylsulphonyl fluoride on the potency of anandamide as an inhibitor of electrically evoked contractions in two isolated tissue preparations. Eur J Pharmacol. 1995 Jan 5;272(1):73–78. doi: 10.1016/0014-2999(94)00618-h. [DOI] [PubMed] [Google Scholar]
  29. Randall M. D., Alexander S. P., Bennett T., Boyd E. A., Fry J. R., Gardiner S. M., Kemp P. A., McCulloch A. I., Kendall D. A. An endogenous cannabinoid as an endothelium-derived vasorelaxant. Biochem Biophys Res Commun. 1996 Dec 4;229(1):114–120. doi: 10.1006/bbrc.1996.1766. [DOI] [PubMed] [Google Scholar]
  30. Rinaldi-Carmona M., Barth F., Héaulme M., Shire D., Calandra B., Congy C., Martinez S., Maruani J., Néliat G., Caput D. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 1994 Aug 22;350(2-3):240–244. doi: 10.1016/0014-5793(94)00773-x. [DOI] [PubMed] [Google Scholar]
  31. Schmid H. H., Schmid P. C., Natarajan V. N-acylated glycerophospholipids and their derivatives. Prog Lipid Res. 1990;29(1):1–43. doi: 10.1016/0163-7827(90)90004-5. [DOI] [PubMed] [Google Scholar]
  32. Schmid H. H., Schmid P. C., Natarajan V. The N-acylation-phosphodiesterase pathway and cell signalling. Chem Phys Lipids. 1996 May 24;80(1-2):133–142. doi: 10.1016/0009-3084(96)02554-6. [DOI] [PubMed] [Google Scholar]
  33. Schmid P. C., Krebsbach R. J., Perry S. R., Dettmer T. M., Maasson J. L., Schmid H. H. Occurrence and postmortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain. FEBS Lett. 1995 Nov 13;375(1-2):117–120. doi: 10.1016/0014-5793(95)01194-j. [DOI] [PubMed] [Google Scholar]
  34. Schmid P. C., Natarajan V., Weis B. K., Schmid H. H. Hydrolysis of N-acylated glycerophospholipids by phospholipases A2 and D: a method of identification and analysis. Chem Phys Lipids. 1986 Oct-Nov;41(3-4):195–207. doi: 10.1016/0009-3084(86)90022-8. [DOI] [PubMed] [Google Scholar]
  35. Schmid P. C., Paria B. C., Krebsbach R. J., Schmid H. H., Dey S. K. Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation. Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):4188–4192. doi: 10.1073/pnas.94.8.4188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Schmid P. C., Reddy P. V., Natarajan V., Schmid H. H. Metabolism of N-acylethanolamine phospholipids by a mammalian phosphodiesterase of the phospholipase D type. J Biol Chem. 1983 Aug 10;258(15):9302–9306. [PubMed] [Google Scholar]
  37. Schmid P. C., Zuzarte-Augustin M. L., Schmid H. H. Properties of rat liver N-acylethanolamine amidohydrolase. J Biol Chem. 1985 Nov 15;260(26):14145–14149. [PubMed] [Google Scholar]
  38. Schuel H., Goldstein E., Mechoulam R., Zimmerman A. M., Zimmerman S. Anandamide (arachidonylethanolamide), a brain cannabinoid receptor agonist, reduces sperm fertilizing capacity in sea urchins by inhibiting the acrosome reaction. Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7678–7682. doi: 10.1073/pnas.91.16.7678. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Schwarz P., Diem R., Dun N. J., Förstermann U. Endogenous and exogenous nitric oxide inhibits norepinephrine release from rat heart sympathetic nerves. Circ Res. 1995 Oct;77(4):841–848. doi: 10.1161/01.res.77.4.841. [DOI] [PubMed] [Google Scholar]
  40. Shen M., Piser T. M., Seybold V. S., Thayer S. A. Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J Neurosci. 1996 Jul 15;16(14):4322–4334. doi: 10.1523/JNEUROSCI.16-14-04322.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Shire D., Carillon C., Kaghad M., Calandra B., Rinaldi-Carmona M., Le Fur G., Caput D., Ferrara P. An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing. J Biol Chem. 1995 Feb 24;270(8):3726–3731. doi: 10.1074/jbc.270.8.3726. [DOI] [PubMed] [Google Scholar]
  42. Stefano G. B., Hall B., Makman M. H., Dvorkin B. Opioid inhibition of dopamine release from nervous tissue of Mytilus edulis and Octopus bimaculatus. Science. 1981 Aug 21;213(4510):928–930. doi: 10.1126/science.6266017. [DOI] [PubMed] [Google Scholar]
  43. Stefano G. B., Liu Y., Goligorsky M. S. Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia, and human monocytes. J Biol Chem. 1996 Aug 9;271(32):19238–19242. doi: 10.1074/jbc.271.32.19238. [DOI] [PubMed] [Google Scholar]
  44. Stefano G. B., Scharrer B., Smith E. M., Hughes T. K., Jr, Magazine H. I., Bilfinger T. V., Hartman A. R., Fricchione G. L., Liu Y., Makman M. H. Opioid and opiate immunoregulatory processes. Crit Rev Immunol. 1996;16(2):109–144. doi: 10.1615/critrevimmunol.v16.i2.10. [DOI] [PubMed] [Google Scholar]
  45. Sugiura T., Kondo S., Sukagawa A., Tonegawa T., Nakane S., Yamashita A., Ishima Y., Waku K. Transacylase-mediated and phosphodiesterase-mediated synthesis of N-arachidonoylethanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes. Comparison with synthesis from free arachidonic acid and ethanolamine. Eur J Biochem. 1996 Aug 15;240(1):53–62. doi: 10.1111/j.1432-1033.1996.0053h.x. [DOI] [PubMed] [Google Scholar]
  46. Sugiura T., Kondo S., Sukagawa A., Tonegawa T., Nakane S., Yamashita A., Waku K. Enzymatic synthesis of anandamide, an endogenous cannabinoid receptor ligand, through N-acylphosphatidylethanolamine pathway in testis: involvement of Ca(2+)-dependent transacylase and phosphodiesterase activities. Biochem Biophys Res Commun. 1996 Jan 5;218(1):113–117. doi: 10.1006/bbrc.1996.0020. [DOI] [PubMed] [Google Scholar]
  47. Tsukahara H., Gordienko D. V., Tonshoff B., Gelato M. C., Goligorsky M. S. Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells. Kidney Int. 1994 Feb;45(2):598–604. doi: 10.1038/ki.1994.78. [DOI] [PubMed] [Google Scholar]
  48. Ueda N., Kurahashi Y., Yamamoto S., Tokunaga T. Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide. J Biol Chem. 1995 Oct 6;270(40):23823–23827. doi: 10.1074/jbc.270.40.23823. [DOI] [PubMed] [Google Scholar]
  49. Van der Kloot W. Anandamide, a naturally-occurring agonist of the cannabinoid receptor, blocks adenylate cyclase at the frog neuromuscular junction. Brain Res. 1994 Jun 27;649(1-2):181–184. doi: 10.1016/0006-8993(94)91062-6. [DOI] [PubMed] [Google Scholar]
  50. Venance L., Piomelli D., Glowinski J., Giaume C. Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes. Nature. 1995 Aug 17;376(6541):590–594. doi: 10.1038/376590a0. [DOI] [PubMed] [Google Scholar]
  51. Wagner A. J., Holstein-Rathlou N. H., Marsh D. J. Internephron coupling by conducted vasomotor responses in normotensive and spontaneously hypertensive rats. Am J Physiol. 1997 Mar;272(3 Pt 2):F372–F379. doi: 10.1152/ajprenal.1997.272.3.F372. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES